Salvianolic acid A eases atherosclerosis in mice by eliminating senescent vascular cells
The compound disrupts an HSP90α complex to trigger endoplasmic reticulum stress and selectively induce apoptosis in senescent smooth muscle cells.
Advanced science (Weinheim, Baden-Wurttemberg, Germany) · Guan X et al. · Paper published 27 Sep 2026
In ApoE-deficient mice fed a high-fat diet and in cultured vascular smooth muscle cells, researchers examined how salvianolic acid A influences atherosclerosis. The team tested the compound alongside targeted overexpression or knockdown of heat shock protein 90 alpha. In cell cultures, salvianolic acid A inhibited heat shock protein 90 alpha, triggering the degradation of protein kinase B and activating PERK signaling. This reaction elevated endoplasmic reticulum-mitochondrial contacts, increased mitochondrial calcium uptake, and induced apoptosis in senescent vascular smooth muscle cells. In mice, treatment reduced the burden of senescent cells, decreased plaque size, and improved the stability of the fibrous cap. Smooth muscle cell-specific knockdown of heat shock protein 90 alpha reproduced these protective effects, whereas overexpressing the protein blocked the therapeutic actions of salvianolic acid A.
Why it matters
Senescent vascular smooth muscle cells actively accelerate arterial disease. Targeting molecular chaperones to clear these dysfunctional cells represents a promising senotherapeutic approach for preserving cardiovascular function during aging.
Caveats
The study was conducted in cell cultures and ApoE-deficient mice fed a high-fat diet, meaning the findings may not directly translate to human vascular aging. Further work is required to determine whether the compound provides safe, long-term cardiovascular benefits in clinical settings.
Written from the paper’s abstract, and every claim checked against it before publishing. Read the paper for the full methods and data.
The paper
Salvianolic Acid a Disrupts the HSP90α-AKT-PERK Ternary Complex to Alleviate Atherosclerosis by Activating Endoplasmic Reticulum Stress of Senescent Vascular Smooth Muscle Cells
Guan X, Lu M, Cui X et al.
Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 27 Sep 2026 · Peer-reviewed
- Relevance
- Relevant
- News value
- Notable
- Evidence
- Animals
- Status
- Peer-reviewed
More on Cellular senescence
See allDasatinib and quercetin reduce liver fibrosis in a phase-2 MASH trial
The senolytic combination improved liver fibrosis without disease worsening in nearly half of treated participants while lowering cellular senescence markers.
Nature metabolism · Koning M et al.
A distinct p21-driven macrophage senotype accumulates during aging and liver disease
Researchers identified a p53-p21-Cyclin D2 axis that governs senescent macrophages in mice and human liver cirrhosis and can be cleared with senolytics.
bioRxiv · Torres G et al.
DNA methylation proxies of senescence markers track human disease and mortality
The new blood-based tools estimate senescence gene activity to predict incident diseases, all-cause mortality, and clinical treatment responses.
medRxiv · Simpson DJ et al.
Bispecific T cell engager eliminates senescent cells in mice and nonhuman primates
Monitored by serum transaminase levels, low doses of the drug alleviated age-related pathologies without causing the hepatotoxicity seen at higher doses.
Aging cell · Deng J et al.
A deep learning score for cellular senescence predicts human mortality and disease risk
The proteomic biomarker tracked chronic illness risk in the UK Biobank and shifted following an 18-month multimodal exercise intervention.
Aging cell · Zhao S et al.